Literature DB >> 32622801

mTORC1 and mTORC2 expression in inner retinal neurons and glial cells.

Mandy K Losiewicz1, Lynda Elghazi1, Diane C Fingar2, Raju V S Rajala3, Stephen I Lentz4, Patrice E Fort5, Steven F Abcouwer1, Thomas W Gardner6.   

Abstract

The retina is one of the most metabolically active tissues, yet the processes that control retinal metabolism remains poorly understood. The mTOR complex (mTORC) that drives protein and lipid biogenesis and autophagy has been studied extensively in regards to retinal development and responses to optic nerve injury but the processes that regulate homeostasis in the adult retina have not been determined. We previously demonstrated that normal adult retina has high rates of protein synthesis compared to skeletal muscle, associated with high levels of mechanistic target of rapamycin (mTOR), a kinase that forms multi-subunit complexes that sense and integrate diverse environmental cues to control cell and tissue physiology. This study was undertaken to: 1) quantify expression of mTOR complex 1 (mTORC1)- and mTORC2-specific partner proteins in normal adult rat retina, brain and liver; and 2) to localize these components in normal human, rat, and mouse retinas. Immunoblotting and immunoprecipitation studies revealed greater expression of raptor (exclusive to mTORC1) and rictor (exclusive for mTORC2) in normal rat retina relative to liver or brain, as well as the activating mTORC components, pSIN1 and pPRAS40. By contrast, liver exhibits greater amounts of the mTORC inhibitor, DEPTOR. Immunolocalization studies for all three species showed that mTOR, raptor, and rictor, as well as most other known components of mTORC1 and mTORC2, were primarily localized in the inner retina with mTORC1 primarily in retinal ganglion cells (RGCs) and mTORC2 primarily in glial cells. In addition, phosphorylated ribosomal protein S6, a direct target of the mTORC1 substrate ribosomal protein S6 kinase beta-1 (S6K1), was readily detectable in RGCs, indicating active mTORC1 signaling, and was preserved in human donor eyes. Collectively, this study demonstrates that the inner retina expresses high levels of mTORC1 and mTORC2 and possesses active mTORC1 signaling that may provide cell- and tissue-specific regulation of homeostatic activity. These findings help to define the physiology of the inner retina, which is key for understanding the pathophysiology of optic neuropathies, glaucoma and diabetic retinopathy.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Protein synthesis; Raptor; Retina; Retinal ganglion cells; Rictor; mTORC

Mesh:

Substances:

Year:  2020        PMID: 32622801      PMCID: PMC7484061          DOI: 10.1016/j.exer.2020.108131

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  46 in total

1.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

Review 2.  Molecular neurobiology of mTOR.

Authors:  Katarzyna Switon; Katarzyna Kotulska; Aleksandra Janusz-Kaminska; Justyna Zmorzynska; Jacek Jaworski
Journal:  Neuroscience       Date:  2016-11-23       Impact factor: 3.590

3.  Characterization of insulin signaling in rat retina in vivo and ex vivo.

Authors:  Chad E N Reiter; Lakshman Sandirasegarane; Ellen B Wolpert; Marianne Klinger; Ian A Simpson; Alistair J Barber; David A Antonetti; Mark Kester; Thomas W Gardner
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-06-10       Impact factor: 4.310

4.  Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway.

Authors:  Kevin Kyungsuk Park; Kai Liu; Yang Hu; Patrice D Smith; Chen Wang; Bin Cai; Bengang Xu; Lauren Connolly; Ioannis Kramvis; Mustafa Sahin; Zhigang He
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

Review 5.  Retinal oxygen: fundamental and clinical aspects.

Authors:  Norbert D Wangsa-Wirawan; Robert A Linsenmeier
Journal:  Arch Ophthalmol       Date:  2003-04

6.  A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation.

Authors:  Guang Yang; Danielle S Murashige; Sean J Humphrey; David E James
Journal:  Cell Rep       Date:  2015-07-30       Impact factor: 9.423

7.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.

Authors:  Andrew R Tee; Diane C Fingar; Brendan D Manning; David J Kwiatkowski; Lewis C Cantley; John Blenis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-23       Impact factor: 11.205

8.  Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance.

Authors:  Patrice E Fort; Mandy K Losiewicz; Chad E N Reiter; Ravi S J Singh; Makoto Nakamura; Steven F Abcouwer; Alistair J Barber; Thomas W Gardner
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

9.  The Utah Protocol for Postmortem Eye Phenotyping and Molecular Biochemical Analysis.

Authors:  Leah A Owen; Akbar Shakoor; Denise J Morgan; Andre A Hejazi; M Wade McEntire; Jared J Brown; Lindsay A Farrer; Ivana Kim; Albert Vitale; Margaret M DeAngelis
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-03-01       Impact factor: 4.799

Review 10.  mTOR as a central hub of nutrient signalling and cell growth.

Authors:  Joungmok Kim; Kun-Liang Guan
Journal:  Nat Cell Biol       Date:  2019-01-02       Impact factor: 28.824

View more
  6 in total

1.  Hyperglycemia-induced VEGF and ROS production in retinal cells is inhibited by the mTOR inhibitor, rapamycin.

Authors:  Teruyo Kida; Hidehiro Oku; Sho Osuka; Taeko Horie; Tsunehiko Ikeda
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

Review 2.  The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases.

Authors:  Kun-Che Chang; Pei-Feng Liu; Chia-Hsuan Chang; Ying-Cheng Lin; Yen-Ju Chen; Chih-Wen Shu
Journal:  Cell Biosci       Date:  2022-01-03       Impact factor: 7.133

3.  CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice.

Authors:  Meng Ye; Jingqiu Huang; Qianxue Mou; Jing Luo; Yuanyuan Hu; Xiaotong Lou; Ke Yao; Bowen Zhao; Qiming Duan; Xing Li; Hong Zhang; Yin Zhao
Journal:  Cell Death Dis       Date:  2021-12-11       Impact factor: 8.469

4.  mTORC1 Activation in Chx10-Specific Tsc1 Knockout Mice Accelerates Retina Aging and Degeneration.

Authors:  Yu-Qing Rao; Yu-Tong Zhou; Wenchuan Zhou; Jia-Kai Li; Baojie Li; Jing Li
Journal:  Oxid Med Cell Longev       Date:  2021-11-05       Impact factor: 6.543

5.  Role of mTORC1 activity during early retinal development and lamination in human-induced pluripotent stem cell-derived retinal organoids.

Authors:  Si Hyung Lee; Jung Woo Han; Jin Young Yang; Hyoung Oh Jun; Ji Hong Bang; Heejeong Shin; Ji Hye Choi; Jongwoo Lee; Sanjar Batirovich Madrakhimov; Kyung Hwun Chung; Hun Soo Chang; Jungmook Lyu; Tae Kwann Park
Journal:  Cell Death Discov       Date:  2022-02-08

Review 6.  mTOR Signalling Pathway: A Potential Therapeutic Target for Ocular Neurodegenerative Diseases.

Authors:  Yipin Wang; Nicholas Siu Kay Fung; Wai-Ching Lam; Amy Cheuk Yin Lo
Journal:  Antioxidants (Basel)       Date:  2022-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.